Theme: “Addressing New Challenges & Emerging Issues in Regenerative Medicine and its allied areas”

Tissuescience 2016

Tissuescience 2016

Sessions and Tracks

The  Global Congress on Tissue Engineering and Regenerative Medicine which is going to be held during December 01-02, 2016 at San Antonio, USA will bring together world-class personalities working on stem cells, tissue engineering and regenerative medicine to discuss materials-related strategies for disease remediation and tissue repair. 

Tissue Regeneration

In the field of biology, regeneration is the progression of renewal, regeneration and growth that makes it possible for genomes, cells, organ regeneration to natural changes or events that cause damage or disturbance. This study is carried out as craniofacial tissue engineering, in-situ tissue regeneration, adipose-derived stem cells for tissue science which is also a breakthrough in cell culture technology. The study is not stopped with the regeneration of tissue where it is further carried out in relation with cell signalling, morphogenetic proteins. Most of the neurological disorders occurred accidental having a scope of recovery by replacement or repair of intervertebral discs repair, spinal fusion and many more advancements. The global market for tissue engineering and regeneration products such as scaffolds, tissue implants, biomimetic materials reached $55.9 billion in 2010 and it is expected to reach $89.7 billion by 2016 at a compounded annual growth rate (CAGR) of 8.4%.  It grows to $135 billion by 2024.

 

Related Conferences

Global Congress on Tissue Engineering and Regenerative Medicine, December 01-02,2016 at San Antonio, USA ;5th International Conference on Tissue Engineering and Regenerative Medicine September 12-14, 2016 Berlin, Germany; 5th International Conference on Cell and Gene Therapy May 19-21, 2016 San Antonio, USA; International Conference on Cancer Immunology and Immunotherapy July 28-30, 2016 Melbourne, Australia; International Conference on Molecular Biology October 13-15, 2016 Dubai, UAE; Tissue Niches and Resident Stem Cells in Adult Epithelia Gordon Research Conference, Regulation of Tissue Homeostasis  by Signalling in the Stem Cell Niche  August 7-12, Hong Kong, China; 10 Years of IPSCs, Cell Symposia, September 25-27, 2016 Berkeley, CA, USA; World Stem Cells and Regenerative Medicine Congress May 18-20, 2016 London, UK; Notch Signaling in Development, Regeneration and Disease Gordon Research Conference,  July 31-August 5, 2016 Lewiston, ME, USA

 

Designs for Tissue Engineering

The developing field of tissue engineering aims to regenerate damaged tissues by combining cells from the body with bioresorbable materials, biodegradable hydrogel, biomimetic materials, nanostructures and nanomaterials, biomaterials and tissue implants which act as templates for tissue regeneration, to guide the growth of new tissue by using with the technologies. The global market for biomaterials, nanostructures and bioresorbable materials are estimated to reach $88.4 billion by 2017 from $44.0 billion in 2012 growing at a CAGR of 15%. Further the biomaterials market estimated to be worth more than 300 billion US Dollars and to be increasing 20% per year.

Related Conferences

Global Congress on Tissue Engineering and Regenerative Medicine, December 01-02,2016 at San Antonio, USA ; 5th International Conference on Cell and Gene Therapy May 19-21, 2016 San Antonio, USA; International Conference on Restorative Medicine October 24-26, 2016 Chicago, USA; Global Congress on Tissue Engineering and Regenerative Medicine, December 01-02,2016 at San Antonio, USA; International Conference on Molecular Biology October 13-15, 2016 Dubai, UAE; 2nd International Conference on Bio-banking August 18-19, 2016 Portland, USA; ISSCR Annual Meeting 22-25 June, 2016 San Francisco, California, USA; Keystone Cardiac Development, Regeneration and Repair (Z2) April 3 – 7, 2016 Snowbird, Utah, USA; EMBL Hematopoietic Stem Cells: From the Embryo to the Aging Organism, June 3-5, 2016 Heidelberg, Germany; ISSCR Pluripotency: From basic science to therapeutic applications March 22-24, 2016 Kyoto, Japan

 

Organ Engineering

This interdisciplinary engineering has attracted much attention as a new therapeutic means that may overcome the drawbacks involved in the current artificial organs and organ transplantation that have been also aiming at replacing lost or severely damaged tissues or organs. Tissue engineering and regenerative medicine is an exciting research area that aims at regenerative alternatives to harvested tissues for organ transplantation with soft tissues. Although significant progress has been made in the tissue engineering field, many challenges remain and further development in this area will require on-going interactions and collaborations among the scientists from multiple disciplines, and in partnership with the regulatory and the funding agencies. As a result of the medical and market potential, there is significant academic and corporate interest in this technology.

Related Conferences

International Conference on Restorative Medicine October 24-26, 2016 Chicago, USA; 5th International Conference on Cell and Gene Therapy May 19-21, 2016 San Antonio, USA; Global Congress on Tissue Engineering and Regenerative Medicine, December 01-02,2016 at San Antonio, USA; 2nd International Conference on Tissue preservation  August 18-19, 2016 Portland, USA; Cell and Gene Therapy January 25-27, 2016 Washington D.C., USA; ISSCR Stem Cell Models of Neural Degeneration and Disease February 1-3, 2016 Dresden, Germany; Craniofacial Morphogenesis and Tissue Regeneration March 12-18, 2016 California, USA; Keystone Stem Cells and Cancer (C1) March 6-10, Colorado, USA; Keystone Stem Cells and Regeneration in the Digestive Organs (X6) March 13 – 17 Colorado, USA

 

Cancer Stem Cells

The characterization of cancer stem cell is done by identifying the cell within a tumor that possesses the capacity to self-renew and to cause the heterogeneous lineages of cancer cells that comprise the tumour. This stem cell which acts as precursor for the cancer acts as a tool against it indulging the reconstruction of cancer stem cells, implies as the therapeutic implications and challenging the gaps globally. The global stem cell market will grow from about $5.6 billion in 2013 to nearly $10.6 billion in 2018, registering a compound annual growth rate (CAGR) of 3.6% from 2013 through 2018. The Americas is the largest region of global stem cell market, with a market share of about $2.0 billion in 2013. The region is projected to increase to nearly $3.9 billion by 2018, with a CAGR of 13.9% for the period of 2013 to 2018. Europe is the second largest segment of the global stem cell market and is expected to grow at a CAGR of 13.4% reaching about $2.4 billion by 2018 from nearly $1.4 billion in 2013.

Related Conferences

5th International Conference Cell and Gene Therapy May 19-21, 2016 San Antonio, USA; International Conference on Molecular Biology October 13-15, 2016 Dubai, UAE; Global Congress on Tissue Engineering and Regenerative Medicine, December 01-02,2016 at San Antonio, USA ; 5th International Conference on Tissue Engineering September 12-14, 2016 Berlin, Germany; 2nd International Conference on Tissue preservation August 18-19, 2016 Portland, USA; Molecular and Cellular Basis of Growth and Regeneration (A3) January 10 – 14, 2016 Colorado, USA; Cell and Gene Therapy January 25-27, 2016 Washington D.C., USA; ISSCR Stem Cell Models of Neural Degeneration and Disease March 13 – 17, 2016 Dresden, Germany; Craniofacial Morphogenesis and Tissue Regeneration March 12-18, 2016 California, USA; World Stem Cells Congress May 18-20, 2016 London, UK; Global Congress on Tissue Engineering and Regenerative Medicine, December 01-02,2016 at San Antonio, USA.

 

Bone Tissue Engineering

Tissue engineering of musculoskeletal tissues, particularly bone and cartilage, is a rapidly advancing field. In bone, technology has centred on bone graft substitute materials and the development of biodegradable scaffolds. Recently, tissue engineering strategies have included cell and gene therapy. The availability of growth factors and the expanding knowledge base concerning the bone regeneration with modern techniques like recombinant signalling molecules, solid free form fabrication of scaffolds, synthetic cartilage, Electrochemical deposition, spinal fusion and ossification are new generated techniques for tissue-engineering applications. The worldwide market for bone and cartilage repairs strategies is estimated about $300 million. During the last 10/15 years, the scientific community witnessed and reported the appearance of several sources of stem cells with both osteon and chondrogenic potential.

Related Conferences

Global Congress on Tissue Engineering and Regenerative Medicine, December 01-02,2016 at San Antonio, USA ; 5th International Conference on Tissue Engineering and Regenerative Medicine September 12-14, 2016 Berlin, Germany; 3rd 2nd International Conference on Tissue preservation and Bio-banking August 18-19, 2016 Portland, USA; Global Congress on Tissue Engineering and Regenerative Medicine, December 01-02,2016 at San Antonio, USA; 5thInternational Conference on Cell and Gene Therapy May 19-21, 2016 San Antonio, USA; International Conference on Restorative Medicine October 24-26, 2016 Chicago, USA; 10th World Biomaterials Congress May 17-22, 2016 Quebec, Canada; 2016 TERMIS-EU Conference June 28- July1, 2016 Uppsala, Sweden; 2016 TERMIS-AP Conference  Tamsui Town of New Taipei City May 23-28, 2016; 2016 TERMIS-AM Conference September 3-6, 2016, San Diego, USA; Pluripotency: From basic science to therapeutic applications 22-24 March 2016 Kyoto, Japan

 

Scaffolds

Scaffolds are one of the three most important elements constituting the basic concept of regenerative medicine, and are included in the core technology of regenerative medicine. Every day thousands of surgical procedures are performed to replace or repair tissue that has been damaged through disease or trauma. The developing field of tissue engineering (TE) aims to regenerate damaged tissues by combining cells from the body with highly porous scaffold biomaterials, which act as templates for tissue regeneration, to guide the growth of new tissue. Scaffolds has a prominent role in tissue regeneration the designs, fabrication, 3D models, surface ligands and molecular architecture, nanoparticle-cell interactions and porous of the scaffolds are been used in the field in attempts to regenerate different tissues and organs in the body. The world stem cell market was approximately 2.715 billion dollars in 2010, and with a growth rate of 16.8% annually, a market of 6.877 billion dollars will be formed in 2016. From 2017, the expected annual growth rate is 10.6%, which would expand the market to 11.38 billion dollars by 2021.

Related Conferences

Global Congress on Tissue Engineering and Regenerative Medicine, December 01-02,2016 at San Antonio, USA; International Conference on Restorative Medicine October 24-26, 2016 Chicago, USA; 5th International Conference on Cell and Gene Therapy May 19-21, 2016 San Antonio, USA; 5th International Conference on Regenerative Medicine September 12-14, 2016 Berlin, Germany; 2nd International Conference on Tissue preservation  August 18-19, 2016 Portland, USA; Cell and Gene Therapy January 25-27, 2016 Washington D.C., USA; ISSCR Stem Cell Models of Neural Degeneration and Disease February 1-3, 2016 Dresden, Germany; Craniofacial Morphogenesis and Tissue Regeneration March 12-18, 2016 California, USA; Keystone Stem Cells and Cancer (C1) March 6-10, Colorado, USA; Keystone Stem Cells and Regeneration in the Digestive Organs (X6) March 13 – 17 Colorado, USA

 

Tissue Regeneration Technologies

Guided tissue regeneration is defined as procedures attempting to regenerate lost periodontal structures through differential tissue responses. Guided bone regeneration typically refers to ridge augmentation or bone regenerative procedures it typically refers to regeneration of periodontal therapy. The recent advancements and innovations in biomedical and regenerative tissue engineering techniques include the novel approach of guided tissue regeneration and combination of nanotechnology and regenerative medicine. 

Related Conferences

International Conference on Restorative Medicine October 24-26, 2016 Chicago, USA; Global Congress on Tissue Engineering and Regenerative Medicine, December 01-02,2016 at San Antonio, USA; International Conference on Molecular Biology October 13-15, 2016 Dubai, UAE; 2nd International Conference on Bio-banking August 18-19, 2016 Portland, USA; ISSCR Annual Meeting 22-25 June, 2016 San Francisco, California, USA; Keystone Cardiac Development, Regeneration and Repair (Z2) April 3 – 7, 2016 Snowbird, Utah, USA; EMBL Hematopoietic Stem Cells: From the Embryo to the Aging Organism, June 3-5, 2016 Heidelberg, Germany; ISSCR Pluripotency: From basic science to therapeutic applications March 22-24, 2016 Kyoto, Japan

 

Regeneration and Therapeutics

Regenerative medicine can be defined as a therapeutic intervention which replaces or regenerates human cells, tissues or organs, to restore or establish normal function and deploys small molecule drugs, biologics, medical devices and cell-based therapies. It deals with the different therapeutic uses like stem cells for tissue repair, tissue injury and healing process, cardiac stem cell therapy for regeneration, functional regenerative recovery, effects of aging on tissue repair/regeneration, corneal regeneration & degeneration. The global market is expected to reach $25.5 billion by 2011 and will further grow to $36.1 billion by 2016 at a CAGR of 7.2%. It is expected to reach $65 billion mark by 2024.

 

Related Conferences

Global Congress on Tissue Engineering and Regenerative Medicine, December 01-02,2016 at San Antonio, USA ; 5th International Conference on Tissue Engineering and Regenerative Medicine September 12-14, 2016 Berlin, Germany; 5th International Conference on Cell and Gene Therapy May 19-21, 2016 San Antonio, USA; International Conference on Cancer Immunology and Immunotherapy July 28-30, 2016 Melbourne, Australia; Global Congress on Tissue Engineering and Regenerative Medicine, December 01-02,2016 at San Antonio, US;  International Conference on Molecular Biology October 13-15, 2016 Dubai, UAE; Tissue Niches and Resident Stem Cells in Adult Epithelia Gordon Research Conference, Regulation of Tissue Homeostasis by Signalling in the Stem Cell Niche  August 7-12, Hong Kong, China; 10 Years of IPSCs, Cell Symposia, September 25-27, 2016 Berkeley, CA, USA; World Stem Cells and Regenerative Medicine Congress May 18-20, 2016 London, UK; Notch Signaling in Development, Regeneration and Disease Gordon Research Conference,  July 31-August 5, 2016 Lewiston, ME, USA

 

Regenerative medicine

Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function. The latest developments involve advances in cell and gene therapy and stem cell research, molecular therapy, dental and craniofacial regeneration. Regenerative medicines have the unique ability to repair, replace and regenerate tissues and organs, affected due to some injury, disease or due to natural aging process. These medicines are capable of restoring the functionality of cells and tissues. The global regenerative medicine market will reach $ 67.6 billion by 2020 from $16.4 billion in 2013, registering a CAGR of 23.2% during forecast period (2014 - 2020). Small molecules and biologics segment holds prominent market share in the overall regenerative medicine technology market and is anticipated to grow at a CAGR of 18.9% during the forecast period.

Related Conferences

Global Congress on Tissue Engineering and Regenerative Medicine, December 01-02,2016 at San Antonio, USA; International Conference on Restorative Medicine October 24-26, 2016 Chicago, USA; 5th International Conference on Cell and Gene Therapy May 19-21, 2016 San Antonio, USA; 5th International Conference on Regenerative Medicine September 12-14, 2016 Berlin, Germany; 2nd International Conference on Tissue preservation  August 18-19, 2016 Portland, USA; Cell and Gene Therapy January 25-27, 2016 Washington D.C., USA; ISSCR Stem Cell Models of Neural Degeneration and Disease February 1-3, 2016 Dresden, Germany; Craniofacial Morphogenesis and Tissue Regeneration March 12-18, 2016 California, USA; Keystone Stem Cells and Cancer (C1) March 6-10, Colorado, USA; Keystone Stem Cells and Regeneration in the Digestive Organs (X6) March 13 – 17 Colorado, USA

 

Applications of Tissue Engineering

The applications of tissue engineering and regenerative medicine are innumerable as they mark the replacement of medication and organ replacement. The applications involve cell tracking and tissue imaging, cell therapy and regenerative medicine, organ harvesting, transport and transplant, the application of nanotechnology in tissue engineering and regenerative medicine and bio banking. Globally the research statistics are increasing at a vast scale and many universities and companies are conducting events on the subject regenerative medicine conference like tissue implants workshops, endodontics meetings, tissue biomarkers events, tissue repair meetings, regenerative medicine conferencestissue engineering conference, regenerative medicine workshop, veterinary regenerative medicine, regenerative medicine symposiums, tissue regeneration conferences, regenerative medicine congress.

Related Conferences

International Conference on Restorative Medicine October 24-26, 2016 Chicago, USA; Global Congress on Tissue Engineering and Regenerative Medicine, December 01-02,2016 at San Antonio, USA;  International Conference on Molecular Biology October 13-15, 2016 Dubai, UAE; 2nd International Conference on Bio-banking August 18-19, 2016 Portland, USA; ISSCR Annual Meeting 22-25 June, 2016 San Francisco, California, USA; Keystone Cardiac Development, Regeneration and Repair (Z2) April 3 – 7, 2016 Snowbird, Utah, USA; EMBL Hematopoietic Stem Cells: From the Embryo to the Aging Organism, June 3-5, 2016 Heidelberg, Germany; ISSCR Pluripotency: From basic science to therapeutic applications March 22-24, 2016 Kyoto, Japan

 

Regenerative Medicine Market

There are strong pricing pressures from public healthcare payers globally as Governments try to reduce budget deficits. Regenerative medicine could potentially save public health bodies money by reducing the need for long-term care and reducing associated disorders, with potential benefits for the world economy as a whole. The global market for tissue engineering and regeneration products reached $55.9 billion in 2010, is expected to reach $59.8 billion by 2011, and will further grow to $89.7 billion by 2016 at a compounded annual growth rate (CAGR) of 8.4%.  It grows to $135 billion to 2024. The contribution of the European region was 43.3% of the market in 2010, a value of $24.2 billion. The market is expected to reach $25.5 billion by 2011 and will further grow to $36.1 billion by 2016 at a CAGR of 7.2%. It grows to $65 billion to 2024.

Related Conferences

Global Congress on Tissue Engineering and Regenerative Medicine, December 01-02,2016 at San Antonio, USA ; 5th International Conference on Tissue Engineering and Regenerative Medicine September 12-14, 2016 Berlin, Germany; 3rd 2nd International Conference on Tissue preservation and Bio-banking August 18-19, 2016 Portland, USA; Global Congress on Tissue Engineering and Regenerative Medicine, December 01-02,2016 at San Antonio, USA; 5thInternational Conference on Cell and Gene Therapy May 19-21, 2016 San Antonio, USA; International Conference on Restorative Medicine October 24-26, 2016 Chicago, USA; 10th World Biomaterials Congress May 17-22, 2016 Quebec, Canada; 2016 TERMIS-EU Conference June 28- July1, 2016 Uppsala, Sweden; 2016 TERMIS-AP Conference  Tamsui Town of New Taipei City May 23-28, 2016; 2016 TERMIS-AM Conference September 3-6, 2016, San Diego, USA; Pluripotency: From basic science to therapeutic applications 22-24 March 2016 Kyoto, Japan


Regenerative Medicine Europe

Leading EU nations with strong biotech sectors such as the UK and Germany are investing heavily in regenerative medicine, seeking competitive advantage in this emerging sector. The commercial regenerative medicine sector faces governance challenges that include a lack of proven business models, an immature science base and ethical controversy surrounding hESC research. The recent global downturn has exacerbated these difficulties: private finance has all but disappeared; leading companies are close to bankruptcy, and start-ups are struggling to raise funds. In the UK the government has responded by announcing £21.5M funding for the regenerative medicine industry and partners. But the present crisis extends considerably beyond regenerative medicine alone, affecting much of the European biotech sector. A 2009 European Commission (EC) report showed the extent to which the global recession has impacted on access to VC finance in Europe: 75% of biopharma companies in Europe need capital within the next two years if they are to continue their current range of activities.

Related Conferences

Global Congress on Tissue Engineering and Regenerative Medicine, December 01-02,2016 at San Antonio, USA; International Conference on Restorative Medicine October 24-26, 2016 Chicago, USA; 5th International Conference on Cell and Gene Therapy May 19-21, 2016 San Antonio, USA; 5th International Conference on Regenerative Medicine September 12-14, 2016 Berlin, Germany; 2nd International Conference on Tissue preservation  August 18-19, 2016 Portland, USA; Cell and Gene Therapy January 25-27, 2016 Washington D.C., USA; ISSCR Stem Cell Models of Neural Degeneration and Disease February 1-3, 2016 Dresden, Germany; Craniofacial Morphogenesis and Tissue Regeneration March 12-18, 2016 California, USA; Keystone Stem Cells and Cancer (C1) March 6-10, Colorado, USA; Keystone Stem Cells and Regeneration in the Digestive Organs (X6) March 13 – 17 Colorado, USA

 

 

Embryonic Stem Cell

Embryonic stem cells are pluripotent, meaning they are able to grow (i.e. differentiate) into all derivatives of the three primary germ layers: ectoderm, endoderm and mesoderm. In other words, they can develop into each of the more than 200 cell types of the adult body as long as they are specified to do so. Embryonic stem cells are distinguished by two distinctive properties: their pluripotency, and their ability to replicate indefinitely. ES cells are pluripotent, that is, they are able to differentiate into all derivatives of the three primary germ layers: ectoderm, endoderm, and mesoderm. These include each of the more than 220 cell types in the adult body. Pluripotency distinguishes embryonic stem cells from adult stem cells found in adults; while embryonic stem cells can generate all cell types in the body, adult stem cells are multipotent and can produce only a limited number of cell types. Additionally, under defined conditions, embryonic stem cells are capable of propagating themselves indefinitely. This allows embryonic stem cells to be employed as useful tools for both research and regenerative medicine, because they can produce limitless numbers of themselves for continued research or clinical use.

Related Conferences

International Conference on Restorative Medicine October 24-26, 2016 Chicago, USA; Global Congress on Tissue Engineering and Regenerative Medicine, December 01-02,2016 at San Antonio, USA; 5th International Conference on Cell and Gene Therapy May 19-21, 2016 San Antonio, USA; 5th International Conference on Regenerative Medicine September 12-14, 2016 Berlin, Germany; 2nd International Conference on Tissue preservation  August 18-19, 2016 Portland, USA; Cell and Gene Therapy January 25-27, 2016 Washington D.C., USA; ISSCR Stem Cell Models of Neural Degeneration and Disease February 1-3, 2016 Dresden, Germany; Craniofacial Morphogenesis and Tissue Regeneration March 12-18, 2016 California, USA; Keystone Stem Cells and Cancer (C1) March 6-10, Colorado, USA; Keystone Stem Cells and Regeneration in the Digestive Organs (X6) March 13 – 17 Colorado, USA

Stem Cell Transplant

Stem cell transplantation is a procedure that is most often recommended as a treatment option for people with leukaemia, multiple myeloma, and some types of lymphoma. It may also be used to treat some genetic diseases that involve the blood. During a stem cell transplant diseased bone marrow (the spongy, fatty tissue found inside larger bones) is destroyed with chemotherapy and/or radiation therapy and then replaced with highly specialized stem cells that develop into healthy bone marrow. Although this procedure used to be referred to as a bone marrow transplant, today it is more commonly called a stem cell transplant because it is stem cells in the blood that are typically being transplanted, not the actual bone marrow tissue.


Related Conferences

5th International Conference Cell and Gene Therapy May 19-21, 2016 San Antonio, USA; International Conference on Molecular Biology October 13-15, 2016 Dubai, UAE; 5th International Conference on Tissue Engineering September 12-14, 2016 Berlin, Germany; 2nd International Conference on Tissue preservation August 18-19, 2016 Portland, USA; Molecular and Cellular Basis of Growth and Regeneration (A3) January 10 – 14, 2016 Colorado, USA; Cell and Gene Therapy January 25-27, 2016 Washington D.C., USA; ISSCR Stem Cell Models of Neural Degeneration and Disease March 13 – 17, 2016 Dresden, Germany; Craniofacial Morphogenesis and Tissue Regeneration March 12-18, 2016 California, USA; World Stem Cells Congress May 18-20, 2016 London, UK; Global Congress on Tissue Engineering and Regenerative Medicine, December 01-02,2016 at San Antonio, USA.

 





About Congress

The  Global Congress on Tissue Engineering and Regenerative Medicine which is going to be held during December 01-02,2016 at San Antonio, USA will bring together world-class personalities working on stem cellstissue engineering and regenerative medicine to discuss materials-related strategies for disease remediation and tissue repair. Bone tissue engineeringsoft tissuestissue imagingtissue implant, cartilage and skin defects are a special focus along with applying basic science and engineering principles from diverse areas towards solving clinically relevant biomedical problems. Conference series LLC Organizes 300+ conferences, 500+workshops and 200+symposiums on Clinical, Medicine, Pharma and Science and Technology every year across USA, Europe, Asia, Middle East, Australia and UK with support from 1000 more scientific societies  and Publishes 500 open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.
 

We welcome you to Tissue Science Conference, to be held on December 01-02, 2016 in San Antonio, USA. This conference presents information regarding cutting-edge developments in all areas of tissue engineering, stem cell research, regenerative medicine research including the biology, medicine, applications and regulations of stem cells. Topics of discussion include recent developments in pre-clinical and clinical trials of stem cell therapy, regenerative medicine and tissue engineering, cancer stem cells, immunotherapy, stem cell reprogramming, and regulatory policies regarding stem cell research.

After the success of the 4th International Conference on Tissue Engineering and Regenerative Medicine Conference in 2015, it is time once again for the tissue engineering and regenerative medicine industries to come together and this time look forward to the next 10 years of commercial successes within these two sectors.

The World Conference on Regenerative Medicine  has traditionally focussed on developing the commercial aspects of  tissue science research, with the addition of innovation within stem cells, regenerative medicine, notably tissue engineering.

Now the first regenerative medicine therapies have made it to market, it is important, for the success of the sector, to move forward and include new projects and innovations that are coming out of academia and university spin-outs. These will be both new developments in regenerative medicine research but also within the use of tissue engineering and stem cells for drug discovery.

Alongside the stem cells content, there is an increasing amount of demand for other forms of regenerative medicine and so the Tissue Science conference will move to include more commercial opportunities within the field of tissue engineering: markedly biological scaffolds, 3D bio printing and organ regeneration.

Through the last 5 years the Tissue Science Conference has built up a reputation for delivering high-level commercial content and bringing together the senior executives and thought-leaders within the space.

 

 

Tissue engineering is an interdisciplinary field that applies the principles of engineering and life sciences toward the development of biological substitutes that restore, maintain, or improve tissue function or a whole organ. Currently it has emerged as a rapidly diversifying field with the potential to address the worldwide organ shortage issue and comprises of tissue regeneration and organ replacement. The global tissue engineering and regeneration market reached $17 billion in 2013. This market is expected to grow to nearly $20.8 billion in 2014 and $56.9 billion in 2019, a compound annual growth rate (CAGR) of 22.3%. On the basis of geography, Europe hold the second place in the global market in the field of regenerative medicine & tissue engineering. In Europe countries like UK, France and Germany are possessing good market shares in the field of regenerative medicine and tissue engineering. Spain and Italy are the emerging market trends for tissue engineering in Europe.

 





Market Analysis

REPORT HIGHLIGHTS

Tissue Engineering is a process involving in-vitro development of tissues or organs. It is done to replace or support the function of defective or injured body part. Tissue engineering involves the application of biology and engineering for innovation of tissue substitutes that can maintain, restore and improve the function of ruptured human tissue. Products developed by this procedure are efficient and durable.  Tissue engineering is gaining its popularity in various areas such as burn treatment or wound care, neurology products, orthopaedics, urological products and others. On the basis of type of material used, tissue engineering and regeneration market can be segmented into synthetic, genetically modified and biological materials. In terms of technology, tissue engineering and regeneration market can be segmented into immunoisolation technology, cell culture technology and stem cell technology.

On the basis of its applications, orthopaedic and dermal sections have the largest market in tissue engineering and regeneration market. North America dominates the global market for tissue engineering and regeneration due to large number of aging people and increasing desire for such surgeries in the region. Europe is expected to experience less growth rate as compared to Asia. This is due to more stringent laws and regulations present in the region. Asia is expected to experience high growth rate in global tissue engineering and regeneration market. Some of the key driving forces for growth of tissue engineering and regeneration market in emerging countries are increasing pool of patients and increasing awareness in these regions. 

Rising cost of organ transplantation and increasing medical applications of 3D printing in tissue and organ regeneration are driving the global tissue engineering and regeneration market. In addition, this technology is gaining popularity due to its efficient products and reduced rejection rates. Varied applications of this technology, for instance, its wound care followed by orthopaedics applications has been driving this market at a high growth rate. Dental and neurologic applications are also expected to drive tissue engineering and regeneration market in near future. Globally, number of regeneration surgeries performed is increasing every year. According to Clear point Medical, which is involved in designing, manufacturing and distribution of compression wear, in 2013, in the U.S., number of reconstruction procedures performed increased by 2% from that in year 2012 and reached a number of about 5.6 million. However, due to slow development, high costs involved in procedure and increasing biological complexity of tissue engineering and regeneration procedures, the global tissue engineering and regeneration market is expected to impede. 

Recent developments in the field of regeneration surgeries, particularly stem cell research, is expected to offer new opportunities for global tissue engineering and regeneration market. Big companies dealing in the market have been involved in partnerships, mergers and acquisitions with smaller companies.  This is one the major trends observed in the global tissue engineering and regeneration market. In addition, companies are focussing on approval and patents for their products.

Market Analysis Report:

 

 





Past Conference Report

Tissue Science Congress

 

Tissue Science 2016 Report

Global Congress on Tissue Engineering and Regenerative Medicine was organized during August 01-02, 2016 at n Antonio, USA. The conference was marked with the attendance of Editorial Board Members of supporting journals, Scientists, young and brilliant researchers, business delegates and talented student communities representing more than 25 countries, who made this conference fruitful and productive.

This conference was based on the theme “Addressing New Challenges & Emerging Issues in Regenerative Medicine and its Allied Areas”. which included the following scientific tracks:  

Stem Cells

Stem Cell Treatments

Rejuvenation

Stem Cell Transplant

Cell Engineering

Bone Tissue Engineering

Tissue preservation

Regenerative Medicine

Tissue Repair and Regeneration

Embryonic Stem Cell

Gene Therapies

Biomaterials and Bioengineering

Models of Regeneration

Tissue Engineering

Scaffolds in Regenerative Medicine

Cellular Therapies

Ethical and Legal Issues

Translational Medicine
 

The Organizing Committee would like to thank the moderator Dr. Margaret Simonian (University of Californian Los Angeles, USA) for her contribution which resulted in smooth functioning of the conference.

The conference proceeded through various scientific sessions and plenary lectures, of which the following topics were highlighted as Keynote presentations:

Ken Yaegaki- Regenerated liver from human tooth pulp treats swine liver failure started by NAFLD (The Nippon Dental University, Japan)

Jia-Qiang He - Cardiac endothelial progenitor cell promotes angiogenesis in mouse hindlimb ischemia (Virginia Tech, USA)

Makoto Komura- Patch tracheoplasty by in body tissue engineering using collagenous connective tissue membranes (biosheets) (Saitama Medical University, Japan)

Margaret Simonian- Proteomics Analysis of Brain Avm Endothelium Post Radiosurgery In Pursuit Of Targets for Molecular Therapies (University of Californian Los Angeles , USA)

Jerry Ray Burgess-  An Integrated Approach To Target Deconvolution, Target Engagement, And Compound Characterization In Live Cells (St. Cloud State University, USA)

 

Various sessions were chaired and co-chaired by: Jia-Qiang He- Virginia Tech, USA; Petra Perner - Institute of Computer Vision and Applied Computer Sciences, Germany ;

ConferenceSeries LLC has taken the privilege of felicitating Tissue Science 2016 Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this conference.

The esteemed guests, keynote speakers and researchers shared their innovative research and vast experience through their informative presentations at the podium of Tissue Science 2016. We are glad to inform that all accepted abstracts for the conference have been published in Journal of Tissue Science & engineering: Open Access as a special issue.

We are also obliged to various experts, company representatives and other eminent scientists who supported the conference by facilitating the discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support, and assistance. With the unique feedback from the conference, ConferenceSeries LLC would like to proudly announce the commencement of the " 2nd Global Congress on Tissue Engineering and Regenerative Medicine " to be organized during August 23,24 at San Francisco, USA.

 Mark your calendars for the upcoming Conference; we are hoping to see you soon!

 


Past Reports  Gallery  



Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date december 1-2, 2016
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Day 1 Day 2
Poster Opportunity Available

Conferenceseries Destinations